Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01935336
Title Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Colorado, Denver

lung cancer



Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST